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Tocopheryl acetate is not oxidized and can penetrate through the skin to the living cells, where about 5% is
converted to free tocopherol and provides beneficial antioxidant effects. Lecithin is one of the main components
of liposomes vesicles forming. The higher the phospholipid used, the more vesicles are formed, so that drug
use is also expected to be optimal. This study aims to determine the effect of increased lecithin concentration
on the efficiency of vitamin E application in liposomes made by thin layer hydration method. In this study
3 formulas were prepared using cholesterol and lecithin with a ratio of 20 mg each:100 mg (F I), 20 mg:400 mg
(F II) and 20 mg:700 mg (F III). Evaluation of liposomes, among others, the efficiency of adsorption, particle
size and morphology. The results showed the formulation of vitamin E in liposome using thin layer hydration
method obtained liposomal adsorption efficiency from F I to F III, respectively that is 41,3799%; 47.6162% and
52.7216%. It can be concluded that an increase in lecithin concentration may increase the efficiency of the
adsorption in which F III is the best formula for improving the efficiency of adsorption.
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1. INTRODUCTION
Drug delivery system is an important part of the drug devel-
opment and treatment. Some examples of targeted particulate
drug delivery systems, among others, microparticles, nanopar-
ticles, microcapsules, microspheres, micelles, lipoproteins, and
liposomes.1 However, from some of these delivery systems, lipo-
somes can only provide preparation characteristic similar to bio-
logical membranes of the body, to localize the drug at the target,
and can improve delivery efficiency into the cytoplasm.2 Almost
all the drug characters can be encapsulated in liposomes to make
modifications on the preparation.
Liposomes are synthetic analogs of natural membranes, an
aqueous vesicle surrounded by a membrane bilayer unilame-
lar or multilamelar. Liposomes are drug delivery system is
unique because it can act as a water-soluble drug carriers or fat
soluble.34
Drug delivery systems such as liposomes, may affect the drug
in the body since during the delivery to the workplaces, drugs are
often confronted with obstacles and interference thereby reduc-
ing the efficacy.7 Vitamin E is a fat-soluble vitamins (lipophilic),
but has difficult to penetrate membrane. Vitamin E is also eas-
ily oxidized, so the shelf life becomes a relatively short time.
∗Author to whom correspondence should be addressed.
Vitamin E formulated into the liposome system aims to increase
the penetration into cells.
In the previous study has been testing the physical charac-
teristics of the combination of salicylic acid liposomes soybean
lecithin 200 mg, 400 mg and 600 mg and 20 mg of cholesterol
made by the thin layer hydration method. Based on the results
obtained liposome vesicle shaped spherical and homogeneous,
measuring about 70 nm to 800 nm in combination formula of
soy lecithin and cholesterol (600 mg:20 mg).
This method of thin layer hydration is the method most widely
used in the manufacture of liposome systems, it is certainty asso-
ciated with the evaporation of the organic solvent and making a
more modest compared to the other methods. Thin-layer hydra-
tion method generally produces liposomes with the type of MLV.
The main ingredient of liposom’s formulation is phospholipid.
Phospholipids are the main elements forming vesicles. Higher
concentration of phospholipid used will produce more vesicles
are formed, so that entrapment of drug are also expected to be
more optimal.7 More vesicles are formed so that more vitamin E
entrapped. But if the concentration of lecithin is too high, it can
decrease the efficiency of entrapment.
This research will be used varying concentrations of lecithin
from previous studies, using the best cholesterol concentrations
than earlier studies to look at the effect of the concentration
of lecithin to the entrapment of vitamin E in liposomes made
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Preparation of liposomes using thin layer hydration method and evaluation.
Ingredients Formula I Formula II Formula III Functions
Vitamin E 50 50 50 Active substance
asetate (mg)
Lecitin (mg) 100 400 700 Lipid phase
Cholesterol (mg) 20 20 20 Lipid phase
Diethyl ether (ml) 15 15 15 Organic solvent
Phosphate buffer 10 10 10 Water phase
pH 7,4 (ml)
Fig. 1. Formula of liposomes vitamin E asetate.
with a thin layer hydration method. Lecithin is used from soy-
bean. Soybean lecithin is a phospholipid from natural materials
which have two acyl chain unsaturated.8 Phospholipids of nat-
ural origin with unsaturated acyl chains are more permeable,
making it easier to adsorb the active substance.9 Selection of
lecithin/phosphatidylcholine in this study because it is the most
widely applied phospholipids in liposomes, have neutral charge,
an inert material, and the price is relatively low compared to
other types of phospholipids.10
2. EXPERIMENTAL DETAILS
The instruments needed were Rotary Evaporator (Eyela n-1000),
Spectrophotometer UV-Vis (Shimadzu), Analytical Balance
(Mettler Toledo), Particle Size Analyzer (Delsa Max), Sonicator
(LAB. Companion), vortex mixer, Microcentrifugation refriger-
ator (BioLion XC-HR20), SEM (Zeiss EVO MA10), and glass
tools.
The materials used in this research were Vitamin E Acetat
(BASF), lecithin (Natural Sourching), cholesterol (Kanto chem-
ical), nitrogen, diethyl ether (MERCK), sodium hydroxide
(Asahimas chemical), potassium hydrogen phosphate (MERCK),
Ethanol Absolute (MERCK), and distilled water.
2.1. Preparation of Maximum Wavelength Vitamin E
Asetat in Absolute Ethanol
Standard solution made by dissolved vitamin E acetate in abso-
lute ethanol to obtain a concentration of 0.01% w/v.11 Spec-
trophotometer set at a wavelength of 200 nm to 400 nm. This
solution was put in a cuvette to be read with a spectrophotometer
spectrum, in order to obtain the maximum wavelength of vitamin
E acetate is 284 nm. The spectrum obtained is printed.
2.2. Preparation of Calibration Curve Vitamin E
Acetate in Absolute Ethanol
Vitamin E acetate solution made with 5 concentrations are
30 ppm, 60 ppm, 90 ppm, 120 ppm and 150 ppm. Spectropho-
tometer set at a wavelength that has been obtained previously.
Each solution of vitamin E acetate absorbance alternately mea-
sured by spectrophotometer. Absorbance obtained is then plotted
on the calibration curve that describes the relationship of con-
centration and absorption, so we get the curve equation.
Liposomes vitamin E made using thin layer hydration method.
Lecithin, cholesterol and vitamin E was weighed, and all the
ingredients are dissolved in 15 ml of diethyl ether. The solution
was evaporated with a rotary evaporator to remove the organic
solvent at a temperature of 45 C±2 C with a speed of 150 rpm
in a vacuum to form a thin layer. Thin-layer is formed and then
purged with nitrogen gas for 1 minute and then allowed to stand
for 24 hours. The next stage, a thin layer of the hydrated with
phosphate buffer pH 7.4 10 ml at temperature of 60±2 C until
the chipped walls entirely of pumpkins. The results of the hydra-
tion process and then put in a vortex for 2 minutes to obtain the
final result of the suspension. Then the suspension reduced size
vesikelnya using sonicator with a frequency of 40 kHz for 5.1213
2.3. Determining of Liposomes Morphology Form
The morphology or physical form of the liposomes was deter-
mined by using Scanning Electron Microscope (SEM). For the
use of SEM, the samples were prepared by means of freeze dry
process, it aimed to dry the sample. After the samples were dry,
the samples coated with Au metal as a conductor. Further, the
samples installed into the specimen room. After that the sam-
ples were analyzed. A picture would appear automatically after
the specimen was set in the specimen room and the vacuum had
been ready. Operating conditions will be optimized, including
auto stigmator, auto contrast, auto brightness. If necessary adjust
the image manually as well to improve image quality.14
2.4. Determination of Liposomes Size Distribution
The particle size distribution was determined by the particle size
analyzer (PSA). The tool was on and waited until all the tool
parameters were ready for use had been fulfilled. Samples were
inserted into the cuvette, and than inserted into the particle size
analyzer tool. The tool was set for sample reading for 3 minutes,
then running the tool till the results was read on a computer
monitor. Then, the data obtained was stored.3 Determination of
particle size distributions made to the liposomes before and after
the particle size is reduced using a sonicator.
2.5. Liposomes Purification and Entrapment
Efficiency Calculation
The liposomes was purified by multilevel centrifugation with
microcentrifugator to separate the entrapped and not entrapped
active substances at a speed of 18,000 rpm for 30 minutes
at a temperature of 4 C in a vacuum,2 then the supernatant
and precipitates were separated. Supernatants then were recen-
trifuged for 30 minutes, the supernatant and precipitates were
separated again. Supernatant obtained then was recentrifuged
for 15 minutes. Through the centrifugation process a separation
between the supernatant and the precipitate was formed.
Supernatant part then was diluted the concentration. Dilution
was done by adding a phosphate buffer pH 7.0 in a 10 ml
flask until the absorbance obtained from the solutions was in
the range of 0.15 to 0.85. After dilution was completed, then
the absorbance was measured alternately by UV-Vis spectropho-
tometer at a wavelength of 258.4. Precipitate part was dissolved
in absolute ethanol and then inserted in the sonicator for 10
minutes,15 it aimed to pull out the entrapped vitamin E acetate
from liposomes vesicles, then the concentration was diluted with
a solvent concentration phosphate buffer pH 7.0 in a 10 ml flask.
The absorption obtained was inserted into the equation of the
calibration curve to obtain the concentration of vitamin E acetate
entrapped within liposomes. The entrapment efficiency was cal-
culated as:16
% EP= xj/xt×100% (1)
EP: entrapment efficiency, xj: entrapped drugs, xt: total drug.
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Fig. 2. Calibrating curve of liposom vitamin E acetate in absolute ethanol.
Entrapment ability of vitamin E in liposomes is measured by
comparing the concentration of vitamin E trapped to the concen-
tration of total vitamin E. The total concentration of vitamin E
obtained from the concentration of trapped vitamin E plus vita-
min E concentrations are free.
3. RESULTS AND DISCUSSION
The results of the determination of vitamin E acetate maximum
wavelength of 0.01% w/v in absolute ethanol showed maximum
absorption at a wavelength of 284.80 nm with the absorbance of
0.5331. This indicates that the active substance used is vitamin E
acetate. After the determination of vitamin E Acetate wavelength,
the calibration curve of Vitamin E acetate in ethanol absolute
is determined. The solution is prepared by 5 different concen-
trations i.e., 30 ppm, 60 ppm, 90 ppm,120 ppm and 150 ppm.
Absorbance is measured using a UV-VIS spectrophotometer at
a wavelength of 284.8 nm and the absorbance obtained sequen-
tially by 0.166; 0.287; 0.411; 0.541; and 0.670. Based on the
relationship between concentration and absorbance, then a linear
line with a correlation coefficient (r) close to 1 is 0.9999 and the
linear regression equation y= 00268+00042867x are obtained.
In this study, vitamin E was formulated in a liposome nanopar-
ticle systems. Each formula is made 3 batches, each batch is
made by 40 ml. Each formula uses a different lecithin concen-
trations, it aims to see the effect of the concentration of lecithin
to the efficiency of the adsorption generated. Selected lecithin
concentration of results orientation and previous research. Of the
three different concentrations of lecithin 100 mg, 400 mg and
700 mg, the concentration which resulted in the entrapment effi-
ciency percentage is best to use lecithin 700 mg. This repre-
sents an increase of efficiency entrapment occurred long with an
increase in lecithin is used.
Fig. 3. Graph entrapment efficiency liposome of vitamin E acetate.
Fig. 4. Comparison graph vesicle size liposomes before and after use son-
icator evaluation of morphology.
3.1. Particle Size Distribution
The results of the measurement of particle size distribution before
sonicated has a range of about 300 nm to 600 nm. The greater
the concentration of lecithin showed the resulting particle size
increases. Increasing the particle size of the liposomes along with
increasing concentrations of lecithin used. Once the particle size
is reduced using a sonicator for 5 minutes with the power of
40 kHz shows a decrease in particle size to produce a range
of 200 to 500 nm. The data show results in the form of vesi-
cles, liposomes LUV (Large Unilamellar vesicles). The reduced
size of liposome particles by using a sonicator a physical effect
on the formation of small bubbles of gases while in hidrofoik
part of the lipid bilayer. The presence of these gases can break
down fragments of the liposome membrane and forming smaller
aggregates.
(a)
(b)
Fig. 5. The results SEM morphology vitamin E acetate liposome with a
magnification of 100 (a) and 280 times (b).
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The results obtained from testing the morphology using SEM
to digital zoom 100 times indicate the formation of vesicles
liposomes. At 280 times magnification can be seen the formation
of an intact liposome vesicles and spherical. From the readings
vitamin E liposome vesicle morphology using SEM looks much
improved vesicle size of the particle measurement results using
PSA (Particle Size Analyzer). This may be caused by the mag-
nification of the size of the vesicles due to the process of freeze
dried and the use of contrast agents is gold that can affect the
size of the vesicles of liposomes.17
3.2. The Entrapment Efficiency
Based on analysis of the one-way ANOVA, gained significance
0000 < 005, it can be concluded that the entrapment efficiency
data has different variants or differences that are affected by the
concentration of lecithin. The entrapment efficiency analysis fol-
lowed by Tukey’s test, the conclusion increase lecithin concen-
tration of 300 mg in each formula has significant influence on
the adsorption efficiency.
Results of ANOVA one way of the data size of the vesicles
after application sonicator shows there are significant differences
between the size of the vesicles at a concentration of lecithin
100 mg of the size of the vesicles at a concentration of lecithin,
400 mg and 700 mg, but there was no significant difference
between the size of the vesicles at a concentration of lecithin
400 mg of the size of the vesicles at a concentration of 700 mg
lecithin.
4. CONCLUSION
Based on the results of this study concluded that the increased
concentration of lecithin which is one of the main com-
ponents making up the liposomes enhance the adsorption
efficiency. The results show that the entrapment efficiency per-
centage consecutively is 41.3799% ± 1.06; 47,6162% ± 0.78;
and 52,7216% ± 1.33, while the vesicles size obtained after
using sonicator is 228 ± 18.09 nm; 372.8 ± 15.91 nm; and
413.9±13.96 nm.
References and Notes
1. D. J. A. Crommelin, W. E. Hennink, and G. Storm, Drug targeting system
fundamentals and aplication to parenteral drug delivery, Drug Delivery and
Targeting for Pharmacist and Pharmaceutical Scientist, Taylor and Francis,
London (2001), pp. 105–129.
2. A. Laouini, C. M. Jaafar, I. B. Limayem, S. Sfar, C. Charcosset, and H. Fessi,
Journal of Colloid Science and Biotechnology 1, 147 (2012).
3. D. D. Lasic, Medical Aplications of Liposomes, Elsevier Science, Amsterdam
(1998).
4. L. Lachman, H. A. Lieberman, and J. L. Kanig, Teori dan Praktek Farmai
Industri, Siti Suyatmi, Terjemahan, UI Press, Jakarta (1994).
5. E. Panjaitan, Jurnal Sains Materi. Indonesia 226 (2008).
6. C. Kaparissides, S. Alexandridou, K. Kotti, and S. Chaitidou, Journal of Nan-
otechnology Online 1 (2006).
7. N. I. Akib, L. Rahman, and M. A. Manggau, Uji Permeasi In vitro gel etosom
vitamin E, Dalam: Majalah Farmasi dan Farmakologi, Universitas Hasanuddin,
Makassar, Hlm (2012), Vol. 16, pp. 1–6.
8. J. C. Boyland and J. Swarbick, Ensyclopedia of Pharmaceutical Technology,
Marcel Darwin Inc., New York (1994), pp. 1–33.
9. V. P. Pandey and M. P. S. Chandran, Dalam: International Journal of Research
in Pharmaceutical and Nano Sciences (2014).
10. M. Sipai Altaf Bhai, V. Yadav, Y. Mamatha, and V. Prasanth, Dalam: Journal
of Pharmaceutical and Scientific Innovation 13 (2012).
11. Anonim, Farmakope Indonesia edisi III, Departemen Kesehatan Republik
Indonesia, Jakarta (1979), p. 755.
12. G. Gregoriadis, Liposome Technology Volume I Preparation of Liposomes,
CRC Press, Inc., Florida (1986).
13. L. A. Al-Zubaidi, M. S. Al-Rubaie, and T. S. Abdullah, Eng. Tech. Journal
32 part (B), 550 (2014).
14. B. V. Mitkari, S. A. Korde, K. R. Mahadik, and C. R. Kokare, Indian Journal of
Pharmaceutical Education and Research 44, 324 (2010).
15. P. Olga, J. Simonovska, Z. Kavrakovski, and V. Rafajlovska, International Jour-
nal of Pharmaceutical and Phytopharmacological Research 13 (2013).
16. N. Ramana Laksmi, S. Swaminathan, R. Udaykumar, and M. K. Uma, Journal
of Biomedhical Science 1 (2010).
17. R. O. Williams and J. M. Vaughn, Nanoparticle Engineering, Dalam:
J. Swarbrick, Encyclopedia of Pharmaceutical Technology, Informa Health
Care USA, New York (2007).
Received: 8 July 2017. Accepted: 19 August 2017.
12513
